Journal of Clinical Endocrinology & Metabolism, Vol 81, 635-640, Copyright © 1996 by Endocrine Society

ARTICLES

Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone

KO Nilsson, K Albertsson-Wikland, J Alm, S Aronson, J Gustafsson, L Hagenas, A Hager, SA Ivarsson, J Karlberg, B Kristrom, C Marcus, C Moell, M Ritzen, T Tuvemo, C Wattsgard, U Westgren, O Westphal and J Aman
Department of Pediatrics, University Hospital Malmo, Sweden.

The spontaneous growth process in Turner's syndrome is characterized by a progressive decline in height velocity during childhood and no pubertal growth spurt. Therefore, therapy aimed at improving height during childhood as well as increasing final height is desirable for most girls with Turner's syndrome. Forty-five girls with Turner's syndrome, 9-16 yr of age (mean age, 12.2 yr), were allocated to three study groups. Group 1 (n = 13) was initially treated with oxandrolone alone; after 1 yr of treatment, GH without (group 1a; n = 6) or with (group 1b; n = 7) ethinyl estradiol was added. Group 2 (n = 17) was treated with GH plus oxandrolone. Group 3 (n = 15) was treated with GH, oxandrolone, and ethinyl estradiol. The dosage were: GH, 0.1 IU/kg.day; oxandrolone, 0.05 mg/kg.day; and ethinyl estradiol, 100 ng/kg.day. A height of 150 cm or more was achieved in 61%, 75%, and 60% of the girls in groups 1, 2, and 3, respectively. The most impressive increase in height was seen in group 2. In this group the mean final height was 154.2 cm (SD = 6.6), which is equivalent to a mean net gain of 8.5 cm (SD = 4.6) over the projected final height. In group 3, in which ethinyl estradiol was included from the start of therapy, the initially good height velocity decelerated after 1-2 yr of treatment. Their mean final height was 151.1 (SD = 4.6) cm, equivalent to a mean net gain of 3.0 cm (SD = 3.8). A similar growth-decelerating effect of ethinyl estradiol was seen in group 1b. We conclude that in girls with Turner's syndrome who are older than 9 yr of age, treatment with GH in combination with oxandrolone results in significant growth acceleration, imitating that in normal puberty, leading to a more favorable height during childhood. This mode of treatment also results in a significantly increased final height, permitting a great number of the girls to attain a final height of more than 150 cm. However, early addition of estrogen decelerates the height velocity and reduces the gain in height.

This article has been cited by other articles:

				M D C Donaldson, E J Gault, K W Tan, and D B Dunger Optimising management in Turner syndrome: from infancy to adult transfer Arch. Dis. Child., June 1, 2006; 91(6): 513 - 520. [Abstract] [Full Text] [PDF]

				J. D. Veldhuis, J. N. Roemmich, E. J. Richmond, A. D. Rogol, J. C. Lovejoy, M. Sheffield-Moore, N. Mauras, and C. Y. Bowers Endocrine Control of Body Composition in Infancy, Childhood, and Puberty Endocr. Rev., February 1, 2005; 26(1): 114 - 146. [Abstract] [Full Text] [PDF]

				V. K. Bakalov, P. L. Van, J. Baron, J. C. Reynolds, and C. A. Bondy Growth Hormone Therapy and Bone Mineral Density in Turner Syndrome J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4886 - 4889. [Abstract] [Full Text] [PDF]

				V. P. Sybert and E. McCauley Turner's Syndrome N. Engl. J. Med., September 16, 2004; 351(12): 1227 - 1238. [Full Text] [PDF]

				G. Massa, C. Heinrichs, S. Verlinde, M. Thomas, J. P. Bourguignon, M. Craen, I. Francois, M. Du Caju, M. Maes, and J. De Schepper Late or Delayed Induced or Spontaneous Puberty in Girls with Turner Syndrome Treated with Growth Hormone Does Not Affect Final Height J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4168 - 4174. [Abstract] [Full Text] [PDF]

				Y. K. van Pareren, S. M. P. F. de Muinck Keizer-Schrama, T. Stijnen, T. C. J. Sas, M. Jansen, B. J. Otten, J. J. G. Hoorweg-Nijman, T. Vulsma, W. H. Stokvis-Brantsma, C. W. Rouwe, et al. Final Height in Girls with Turner Syndrome after Long-Term Growth Hormone Treatment in Three Dosages and Low Dose Estrogens J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1119 - 1125. [Abstract] [Full Text] [PDF]

				J. G. Hreinsson, M. Otala, M. Fridstrom, B. Borgstrom, C. Rasmussen, M. Lundqvist, T. Tuuri, N. Simberg, M. Mikkola, L. Dunkel, et al. Follicles Are Found in the Ovaries of Adolescent Girls with Turner's Syndrome J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3618 - 3623. [Abstract] [Full Text] [PDF]

				C. Christmas, K. G. O'Connor, S. M. Harman, J. D. Tobin, T. Munzer, M. F. Bellantoni, C. St. Clair, K. M. Pabst, J. D. Sorkin, and M. R. Blackman Growth Hormone and Sex Steroid Effects on Bone Metabolism and Bone Mineral Density in Healthy Aged Women and Men J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2002; 57(1): M12 - 18. [Abstract] [Full Text] [PDF]

				C. Ankarberg-Lindgren, M. Elfving, K. A. Wikland, and E. Norjavaara Nocturnal Application of Transdermal Estradiol Patches Produces Levels of Estradiol That Mimic Those Seen at the Onset of Spontaneous Puberty in Girls J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3039 - 3044. [Abstract] [Full Text] [PDF]

				E. O. Reiter, S. L. Blethen, J. Baptista, and L. Price Early Initiation of Growth Hormone Treatment Allows Age-Appropriate Estrogen Use in Turner's Syndrome J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1936 - 1941. [Abstract] [Full Text]

				D I Johnston, P Betts, D Dunger, N Barnes, P G F Swift, J M H Buckler, and G E Butler A multicentre trial of recombinant growth hormone and low dose oestrogen in Turner syndrome: near final height analysis Arch. Dis. Child., January 1, 2001; 84(1): 76 - 81. [Abstract] [Full Text]

				S. D. Chernausek, K. M. Attie, J. F. Cara, R. G. Rosenfeld, and J. Frane Growth Hormone Therapy of Turner Syndrome: The Impact of Age of Estrogen Replacement on Final Height J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2439 - 2445. [Abstract] [Full Text]

				T. C. J. Sas, S. M. P. F. de Muinck Keizer-Schrama, T. Stijnen, H. J. Aanstoot, and S. L. S. Drop Carbohydrate Metabolism during Long-Term Growth Hormone (GH) Treatment and after Discontinuation of GH Treatment in Girls with Turner Syndrome Participating in a Randomized Dose-Response Study J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 769 - 775. [Abstract] [Full Text]

				H. Guyda Four Decades of Growth Hormone Therapy for Short Children: What Have We Achieved? J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4307 - 4316. [Full Text]

				Growth-Promoting Strategies in Turner's Syndrome J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4345 - 4348. [Full Text]

				Final Height of Patients with Turner's Syndrome Treated with Growth Hormone (GH): Indications for GH Therapy Alone at High Doses and Late Estrogen Therapy J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4510 - 4515. [Abstract] [Full Text]

				T. Sas Normalization of Height in Girls with Turner Syndrome after Long-Term Growth Hormone Treatment: Results of a Randomized Dose-Response Trial J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4607 - 4612. [Abstract] [Full Text]

				Body Proportions during Long-Term Growth Hormone Treatment in Girls with Turner Syndrome Participating in a Randomized Dose-Response Trial J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4622 - 4628. [Abstract] [Full Text]

				P R Betts, G E Butler, M D C Donaldson, D B Dunger, D I Johnston, C J H Kelnar, J Kirk, D A Price, P Wilton, and the UK KIGS Executive Group on behalf of the parti A decade of growth hormone treatment in girls with Turner syndrome in the UK Arch. Dis. Child., March 1, 1999; 80(3): 221 - 225. [Abstract] [Full Text]

				T. C J Sas, S M P F d. M. Keizer-Schrama, T. Stijnen, A van Teunenbroek, A C S Hokken-Koelega, J J J Waelkens, G G Massa, T. Vulsma, W J Gerver, H M Reeser, et al. Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections Arch. Dis. Child., January 1, 1999; 80(1): 36 - 41. [Abstract] [Full Text]

				J.-C. Carel, L. Mathivon, C. Gendrel, J.-P. Ducret, and J.-L. Chaussain Near Normalization of Final Height with Adapted Doses of Growth Hormone in Turner's Syndrome J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1462 - 1466. [Abstract] [Full Text]

				C. Dacou-Voutetakis, K. Karavanaki-Karanassiou, V. Petrou, N. Georgopoulos, M. Maniati-Christidi, and A. Mavrou The Growth Pattern and Final Height of Girls With Turner Syndrome With and Without Human Growth Hormone Treatment Pediatrics, April 1, 1998; 101(4): 663 - 668. [Abstract] [Full Text] [PDF]

				P. E Clayton and V. Tillmann Advances in endocrinology Arch. Dis. Child., March 1, 1998; 78(3): 278 - 284. [Full Text]

				P. Saenger Turner's Syndrome N. Engl. J. Med., December 5, 1996; 335(23): 1749 - 1754. [Full Text] [PDF]